Evidence map›Paper›PMID 35035808›Full record

ArticleJournal of healthcare engineering2022

Study on Toll-Like Receptor 2-Mediated Inflammation-Induced Familial Hypertension Combined with Hyperlipemia and Its Mechanism.

Jia Liu, Chunjing Li, Qiuyang Wang, Haiyan Hu, Chunhong Li, Jiuguang Qian

RetractedOpen access · hybridAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jia LiuDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar 161041, China.ORCID 0000-0001-6046-0664
Chunjing LiDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar 161041, China.ORCID 0000-0002-5453-3211
Qiuyang WangDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar 161041, China.ORCID 0000-0002-1019-0640
Haiyan HuDepartment of General Practice, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar 161041, China.ORCID 0000-0001-6789-1635
Chunhong LiDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar 161041, China.ORCID 0000-0002-4468-1317
Jiuguang QianDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar 161041, China.ORCID 0000-0002-8835-8466
Qiqihar Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

According to the latest clinical data, cardiovascular diseases have ranked first in prone diseases, causing 40% of the premature deaths of China's population. This study aimed to investigate the influence of Toll-like receptor 2- (TLR2-) mediated inflammation on the occurrence and development of familial hypertension combined with hyperlipemia and its related mechanism. Blood specimens from 66 patients undergoing coronary atherosclerosis were collected and grouped, including 22 patients into the control group, 25 into the familial hypertension group, and 19 into familial hypertension combined with hyperlipemia group. In this study, ELISA was conducted for determining the levels of four inflammatory factors of TLR2 and IL-1

Indexed as

HyperlipidemiasHypertensionToll-Like Receptor 2AnimalsHumansInflammationInterleukin-6MiceNF-kappa BProto-Oncogene Proteins c-aktTumor Necrosis Factor-alphaInterleukin-6NF-kappa BProto-Oncogene Proteins c-aktTlr2 protein, mouseToll-Like Receptor 2Tumor Necrosis Factor-alpha

Identifiers

PMID35035808
PMCPMC8754591
OpenAlexW4206210189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.